Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-L-Alaninol

    • Product Name Fmoc-L-Alaninol
    • Alias (S)-2-Amino-N-(9H-fluoren-9-ylmethoxycarbonyl)propan-1-ol
    • Einecs 621-592-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    867519

    Product Name Fmoc-L-Alaninol
    Cas Number 117305-98-1
    Molecular Formula C18H19NO2
    Molecular Weight 281.35
    Appearance White to off-white solid
    Purity Typically ≥98%
    Melting Point 81-84°C
    Solubility Soluble in DMSO, methanol, ethanol
    Storage Temperature 2-8°C
    Protection Group Fmoc (9-fluorenylmethyloxycarbonyl)
    Optical Activity [α]20/D +10° to +13° (c=1, methanol)
    Synonyms Fmoc-L-alaninol, Fmoc-L-2-aminopropanol
    Usage Amino alcohol building block for peptide synthesis
    Inchi InChI=1S/C18H19NO2/c1-13(19)11-21-18(20)15-8-4-2-6-12-16(15)14-9-3-5-10-17(12)14/h2-10,13H,11,19H2,1H3
    Smiles CC(CO)NCC(=O)OCC1=CC2=CC=CC=C2C3=CC=CC=C31

    As an accredited Fmoc-L-Alaninol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Fmoc-L-Alaninol (5 g) features a sealed amber glass bottle with a white screw cap and labeled with chemical details.
    Shipping Fmoc-L-Alaninol is shipped in tightly sealed containers under ambient or cool conditions to prevent moisture and light exposure. Packaging complies with chemical transport regulations, utilizing protective cushioning and labeling for safe handling. A certificate of analysis and safety data sheet (SDS) are included to ensure proper identification and safe delivery.
    Storage Fmoc-L-Alaninol should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated environment. Ideally, it should be kept at 2-8°C (refrigerated) to maintain stability. Avoid exposure to strong acids, bases, and oxidizing agents. Proper chemical handling procedures and personal protective equipment (PPE) should be used when storing or handling this compound.
    Application of Fmoc-L-Alaninol

    Applications of Fmoc-L-Alaninol in Industrial Manufacturing

    Fmoc-L-Alaninol serves key functions across peptide synthesis research, pharmaceutical intermediate production, customized peptide scale-up, and the development of conjugated biopolymer materials. As a manufacturer, we support complex downstream processes by providing high-purity Fmoc-L-Alaninol tailored to each sector’s requirements, driving innovation and product quality in regulated and technology-driven markets.

    1. Solid Phase Peptide Synthesis (SPPS) in Research Laboratories

    Research laboratories use Fmoc-L-Alaninol as an essential protected amino alcohol during the stepwise assembly of synthetic peptides using solid-phase methods. It enables incorporation of non-standard residues or C-terminal modifications where alcohol functionality is required. Precise protection ensures minimal racemization and efficient Fmoc deprotection. High material reliability is critical due to stringent research reproducibility standards, which affect biological activity and analytical validation outcomes.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • ISO 9001:2015 Quality Management Systems
    • Analytical certification traceable to NIST standards
    • OECD GLP (Good Laboratory Practice) for non-clinical research

    Typical usage ratio

    • 0.8–1.2 molar equivalents per peptide coupling step
    • Adjustment based on resin loading capacity and peptide length

    Downstream process integration

    • Loaded onto pre-functionalized resins for chain elongation
    • Participates in base-mediated Fmoc deprotection cycles
    • Undergoes selective cleavage from the resin under acidic conditions

    Final product types

    • Custom peptides for molecular biology tools
    • Reference peptides for assay controls
    • Bioactive peptide fragments for target validation

    2. Pharmaceutical Intermediates Manufacturing

    Pharmaceutical companies utilize Fmoc-L-Alaninol as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs) and intermediates, especially where chiral C-terminal alcohols or amide analogs are specified. The use of this raw material supports batch-to-batch consistency across regulated synthetic routes, minimizing byproducts and impurities that would otherwise complicate downstream isolation and purification. Full traceability supports quality release under regulatory frameworks.

    Industry compliance standards

    • US FDA cGMP for pharmaceuticals (21 CFR Parts 210/211)
    • EU EudraLex Volume 4 – GMP Guidelines
    • USP, EP, JP monographs when applicable
    • ICH Q3A/B for impurity profiling

    Typical usage ratio

    • Stoichiometric or slight excess (1.0–1.25 eq.) relative to coupling partners
    • Ratio tailored to synthesis stage and impurity constraints

    Downstream process integration

    • Inserted at the chiral introduction step for final API assembly
    • Integrated into protected fragment condensations
    • Subject to in-process controls for chirality and purity

    Final product types

    • Peptidomimetic drug intermediates
    • Biosimilar peptide actives
    • Specialty chiral auxiliaries

    3. Scale-Up Production of Modified Peptides

    Contract manufacturing organizations and biotech firms deploy Fmoc-L-Alaninol for cGMP-scale syntheses where small peptide modifications alter physicochemical properties or bioactivity. Its use in multi-kilogram scale demands strict in-process analytical monitoring and compatibility with automated reactor and chromatography systems. Manufacturers ensure robust supply chain traceability to eliminate cross-contamination risks during parallel batch campaigns.

    Industry compliance standards

    • ICH Q11 for development and manufacture of drug substances
    • EU Annex 15 Qualification and Validation
    • API manufacturing site GMP certification
    • Electronic batch record traceability per 21 CFR Part 11

    Typical usage ratio

    • Standard coupling: 1.0–1.1 equivalents per reaction
    • Process-optimized based on solubility and yield profiles

    Downstream process integration

    • Fed via dedicated feed lines into reactor systems
    • Paired with automated Fmoc deprotection and cleavage cycles
    • Purification via preparative HPLC or simulated moving bed chromatography

    Final product types

    • Bulk-modified peptide APIs for injectable formulations
    • Conjugatable peptide intermediates for ADCs
    • Generic oligopeptide actives for high-volume supply

    4. Functionalized Biopolymer and Peptide-Polymer Conjugate Production

    Specialty materials manufacturers employ Fmoc-L-Alaninol to introduce terminal alcohol or amine functionalities on synthetic or semi-synthetic polymeric backbones via controlled peptide synthesis techniques. Such modifications enhance coupling to fluorescent dyes, polymer chains, or surface coatings, supporting the creation of biomaterials with tailored interaction profiles. Rigorous control of functional group preservation under processing conditions ensures downstream grafting efficiency.

    Industry compliance standards

    • ISO 13485 for medical device components with peptide content
    • ISO 10993 for biological evaluation of biomaterials
    • REACH registration for production volumes above 1 metric ton/year
    • Material safety assessment under EU CLP regulations

    Typical usage ratio

    • 0.5–1.5 molar equivalents per active polymer site
    • Optimized according to desired grafting density and reactivity

    Downstream process integration

    • Introduced at the functionalization step of biopolymer synthesis
    • Combined with click chemistry or activated ester coupling protocols
    • Final purification by membrane ultrafiltration or selective crystallization

    Final product types

    • Peptide-polymer conjugates for drug delivery and coatings
    • Functionalized hydrogel precursors for biomedical scaffolds
    • Biolabeling reagents for diagnostic kits
    Free Quote

    Competitive Fmoc-L-Alaninol prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-L-Alaninol: A Closer Look from Our Production Floor

    Introduction and Insights Gained from Years in Synthesis

    Every batch of Fmoc-L-Alaninol that leaves our facility comes after dozens of decisions made by chemists with years of hands-on experience. The compound itself, marked by the Fmoc-protected L-Alaninol backbone, finds steady demand in peptide research and synthesis workflows. On our production floor, those details become real: the density of its crystalline powder, the unmistakable scent in the drying room, the sharp reliability in thin-layer chromatography. Our own technicians have handled enough variants of Fmoc-protected amino alcohols to recognize what sets Fmoc-L-Alaninol apart—its reproducibility from batch to batch, and the way it bridges pure research and scalable applications.

    Our Approach to Quality and Consistency

    There are no shortcuts to reliable Fmoc-L-Alaninol. Each order starts at the raw material dock, where high-grade L-Alanine is selected for conversion. The Fmoc group attaches in a protected environment using a well-practiced reaction sequence; we've scaled this route over the years, using solvents and reagents that leave minimal trace impurities. Drying takes place under controlled temperatures to avoid racemization or hydrolysis. Hands-on quality checks catch shifts in physical appearance or solvent residues long before we reach purity verification—by then, most imperfections have been weeded out. Our analytical results consistently show purity levels exceeding 99 percent, matching the requirements set by academic peptide labs and commercial drug discovery programs.

    Why Fmoc-L-Alaninol Matters to Chemistry

    This molecule becomes especially valuable during the assembly of peptide chains on solid support. Fmoc-L-Alaninol isn’t a bench curiosity; it’s a foundational building block for complex peptide and peptidomimetic structures. The compound provides an optimal backbone geometry due to the sec-amine functional group, making it a go-to choice for introducing protected amino alcohols without unwanted sequence alteration. Experienced researchers observe quicker coupling, fewer deletion sequences, and a marked reduction in side-product formation when sourcing from a tightly controlled manufacturing process. These improvements rarely appear in spec sheets, but they show up every time staff in analytical, purification, or scale-up groups comment on yield and clarity.

    Specifications Backed by Experience

    Our Fmoc-L-Alaninol is delivered in solid, white crystalline form, odor faint but distinctive when freshly produced. Moisture checks fall below the accepted moisture threshold, and every container undergoes customized packaging to prevent clumping or contamination from atmospheric humidity. Storage recommendations are not printed from templates; they reflect what our team learned during long- or short-term stock rotation. We monitor melting point and solubility shifts that can occur with these sensitive Fmoc intermediates, intervening at the process level before anything unusual reaches the customer lab.

    Differences from Other Fmoc-Protected Amino Alcohols

    Researchers increasingly focus on nuanced outcomes: isomeric purity, reaction rate improvements, downstream deprotection profiles, and overall chain extension yield. Fmoc-L-Alaninol distinguishes itself through the use of an L-alanine base rather than bulkier amino acids, resulting in a backbone with minimal steric hindrance. This subtle difference means easier subsequent coupling, especially in automated synthesizers where blocked cycles reduce efficiency. Our compound’s moderate hydrophobicity and defined reactivity make it less likely to cause aggregation during chain assembly—a regular issue with more hindered or hydrophobic Fmoc derivatives.

    Use Cases in the Lab and Beyond

    Most of the Fmoc-L-Alaninol we ship ends up downstream of academic and industrial peptide synthesis. It serves as a critical intermediate for both linear and cyclic peptide projects, and its protected amine makes for efficient insertion into growing chains. In peptide drug research, minor differences in molecular structure lead to pronounced efficacy shifts. Our product enables systematic SAR (structure–activity relationship) studies, where chemists swap Fmoc-L-Alaninol for other protected amino alcohols and immediately observe effects on binding or stability. Users in chemical biology deploy Fmoc-L-Alaninol for custom linker synthesis, conjugation to labels, or as a precursor for advanced building blocks unlikely to ever appear in a catalog.

    Learnings: Raw Materials and Purification Nuances

    We remember when global supply chains forced us to vet new L-alanine sources. Some batches of raw amino acid can carry micro-level impurities—proline, aspartate, or trace metals—that seem insignificant until they carry through to the final product. Our purification methods catch these discrepancies before customers see unexpected mass spec peaks or problematic side reactions. Most of our production issues in the early years stemmed from these sources, and tweaking our suppliers and purification line revealed just how sensitive downstream chemistry can be. Standard silica column or crystallization didn’t always cut it, so we invested in newer flash chromatography and resin-based technologies. These improvements paid off in more reliable product, not just on the HPLC but in kinetic studies, coupling efficiencies, and scale-up reproducibility.

    Environmental Responsibility in Manufacturing

    Fmoc-protected compounds carry an environmental cost, especially in the solvents used and the by-products produced during protection and deprotection. Our facility has phased out especially toxic carriers and reuses process solvents in a closed-loop system. The NMR tubes and glassware get their own attention; no residual piperidine or DMSO is tolerated between runs. Our in-house staff lead waste reduction efforts, experimenting with solvent swaps and greener deprotection methods when customer protocols allow. Reducing batch waste isn’t about marketing; it saves costs, reduces incident reports, and lines up with increasingly strict regulatory and customer demands.

    Supporting Cutting-Edge Research and Industry Goals

    Some of the labs using Fmoc-L-Alaninol base their projects around bespoke peptide sequences, relying on our tight spec controls to reduce purification headaches down the line. We recall feedback from a team running high-throughput synthesis lines: their peptide yields spiked after shifting to our batches, while side-chain racemization incidents dropped. For companies engineering new therapeutic scaffolds, minute changes in the starting material affect clinical outcomes and regulatory filings. Our continuous improvement stems not from external pressure, but because we see how tiny lapses can derail entire projects. In turn, every new analytical insight, from optical rotation data to microanalytical carbon-hydrogen-nitrogen testing, feeds back into our production cycle.

    Working with Customers: What Feedback Has Taught Us

    Over time, requests shifted from standard specs to more demanding tolerances—narrower melting point ranges, lower by-product guarantees, and semi-custom lot tracking. Leading academic labs often call our team to discuss batch history and analytical records prior to ordering for a major synthesis. It is clear that reducing synthetic ambiguity is invaluable when hundreds of milligrams stand between a successful sequence and wasted reagents. Manufacturers downstream, especially those in regulated spaces, regularly submit our certificates of analysis to their own compliance departments. This partnership has driven us to incorporate third-party analytical validation and even in-process quality snapshots accessible upon request.

    Safety Considerations from a Manufacturer’s Perspective

    Producing Fmoc-L-Alaninol means understanding the material’s interaction with glass, metals, and personnel. Staff training does not stop at safety goggles; every technician knows how to handle Fmoc reagents in clean areas, manage spills, and prevent cross-contamination between aminos and the myriad other products flowing through our plant. Our protocols emphasize protective measures to ensure everyone on site understands the short- and long-term hazards of Fmoc-protected intermediates. Feedback from onsite audits and our own near-miss reporting has reduced minor incidents, while improved air quality monitoring ensures no chronic low-dose exposure accrues over years of work.

    Shelf Life, Storage and Stability Insights

    We’ve tracked the long-term stability of Fmoc-L-Alaninol under actual storage conditions—desiccators, refrigerated storage, and standard warehouse racks. Over months, the compound proves stable provided simple precautions protect it from high humidity and direct sunlight. Our own archived reference samples undergo periodic retesting, with HPLC purity well within original specifications long after initial production. These records have helped clients reduce their own logistical uncertainties, especially during planning for large peptide runs where ingredient degradation could force costly delays.

    Comparisons and Real-World Substitution Scenarios

    Labs ask about switching from structurally similar Fmoc-amino alcohols, wondering if minor backbone changes will influence their sequences. Direct side-by-side tests carried out for long-term users have revealed cleaner cleavage and fewer residual fragments with our Fmoc-L-Alaninol, especially during preparative-scale operations. High-throughput research centers, using automated synthesizers, comment on fewer stuck cycles and lower resin fouling rates with our batches compared to bulk lots from less transparent sources. Differences are rarely dramatic but, for teams running iterative synthesis, even one extra stuck cycle means hours of troubleshooting.

    Production Scale: Batch Ranges and Customer Needs

    Our operations run batches tailored to research and pilot plant quantities—the same level of oversight applies whether shipping a 5-gram jar or a multi-kilogram drum. We learned from early, smaller-scale mistakes that ignoring scale-related purification quirks leads to inconsistencies in yield and purity. Every scale-up received new process checklists and, with input from internal and customer-side chemists, purification stages remain consistent as batches get larger. Tracking variables like temperature, pH swings, and reaction time, we continue to lower variability between batches. For users scaling up from milligram method development to multigram process work, these stability and purity trends prevent surprises and costly rework.

    Regulatory and Documentation Practices

    Though most Fmoc-L-Alaninol prepared on our site is destined for research, requests for documentation supporting regulatory filings are frequent. Our QC practices generate detailed batch histories, spectra archives, contaminant logs, and other records supporting traceability. This helps downstream users facing audits or compliance reviews, confident that our product supports their due diligence. Discussions with compliance officers drive changes to our own record-keeping routines, ensuring we remain ready for evolving regulatory environments.

    Innovation and Future Development

    The chemistry world constantly evolves, which means our production methods do as well. Lately, more innovative approaches for protecting group chemistry and environmentally safer solvent systems have made their way into our Fmoc-L-Alaninol workflow. We review protocols from leading academic groups and hold regular sessions with our R&D team to stay ahead of potential challenges. Small advancements—like shorter reaction cycles or new drying techniques—eventually show up in our delivered product. We believe that manufacturing must stay firmly rooted in practical lab reality, not just process charts or spec sheets.

    Conclusion: Keeping Fmoc-L-Alaninol Useful and Reliable

    Making Fmoc-L-Alaninol for researchers and industry professionals is about more than entering a formula and packaging a white powder. It’s a continuous interaction with science, production, safety, compliance, and customer needs. No batch is a repeat of the one before; every step reflects years spent refining, troubleshooting, and adjusting methods to achieve a product that stands up to the real demands of modern peptide chemistry. Whether being used in the earliest stages of drug design or in creating educational tools for the next generation of scientists, our Fmoc-L-Alaninol continues to prove itself reliable across countless labs around the world.